Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Selangor, Malaysia, May 22, 2026 (GLOBE NEWSWIRE) -- Empro Group Inc. (Nasdaq: EMPG) (“Empro Group” or the “Company”), a rising beauty and personal care brand headquartered in Malaysia, today...
-
Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast. NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- World Street Intelligence...
-
Xeriant (OTCQB: XERI) signs MOU with UAV Corp. (OTCPK: UMAV) to pursue a strategic combination and to explore advanced space-age materials integration
-
Central Bancompany, Inc. Announces Conference Call to Discuss Second Quarter 2026 Results
-
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002 to Jupiter Neurosciences in a Transaction Valued at Over $100 Million USD
-
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc....
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Commvault To Contact Him Directly To Discuss Their Options If you purchased or...
-
Orion Announces Preliminary FY26 Revenue of $86M and Approximately $2M Adjusted EBITDA; Reiterates Expectations for Increased Growth and Profitability
-
NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gossamer Bio, Inc. (NASDAQ: GOSS) between June 16, 2025 and...
-
Israeli Ministry of Health approved the initiation of Silexion's Phase 2/3 clinical trial of SIL204 in locally advanced pancreatic cancer Clinical Trial Application subsequently submitted to Germany...